SMLR
ANALYST COVERAGE7 analysts
BUY
+148.4%upside to target
L $40.00
Med $50.50consensus
H $61.00
Buy
686%
Hold
114%
6 Buy (86%)1 Hold (14%)0 Sell (0%)
Full report →
Key MetricsTTM
Market Cap$310.75M
Revenue TTM$36.96M
Net Income TTM$48.34M
Free Cash Flow-$388.75M
Gross Margin90.8%
Operating Margin-94.7%
Net Margin130.8%
Return on Equity15.6%
Return on Assets8.1%
Debt / Equity0.25
Current Ratio1.97
EPS TTM$3.26
PRICE
Prev Close
21.37
Open
20.33
Day Range
52W Range14.89 – 65.98
14.89
65.98
11% of range
VOLUME & SIZE
Avg Volume
647.9K
FUNDAMENTALS
P/E Ratio
3.9x
Value territory
EPS (TTM)
Div Yield
No dividend
Beta
1.39
Market-like
TECHNICAL
RSI (14)
55
Bullish momentum
Upcoming Events
EEarnings Report
Tomorrow
May 23
DEx-Dividend
In 90 days
Aug 20
PDividend Pay
In 116 days
Sep 15

SMLR News

About

semler scientific, inc. is an emerging medical risk-assessment company whose diagnostic and testing products and services help to guide patient care and close the gap between cost of care and compensation for care. semler closed the initial public offering of its common stock on february 26, 2014 and its common stock is now listed under the ticker symbol "smlr."​ additional information about semler can be found at www.semlerscientific.com.

Industry
Surgical and Medical Instrument Manufacturing
CEO
Douglas Murphy-Chutorian
Douglas Murphy-ChutorianChief Executive Officer, Interim Chief Financial Officer, President & Director
Herbert J. SemlerFounder & Chairman Emeritus
Joe BurnettDirector of Bitcoin Strategy
Eric H. SemlerExecutive Chairman of the Board
Cindy GuinassoSenior Vice President of Business Development